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Pulmonary tuberculosisAbstract Mycobacterium tuberculosis, acid fast bacilli from the family of Mycobacteriaceae, is the
causative agent of most cases of tuberculosis. Tuberculosis, as a communicable disease, remains a
serious public health threat, killing more than one million people globally every year. Primary diag-
nosis of tuberculosis bacilli (TB) relies mainly on microscopic detection of acid fast bacilli (AFB),
but the method suffers from low sensitivity and the results largely depend on the technician’s skill.
New diagnostic tools are necessary to be introduced for rapid and accurate detection of the bacilli in
sputum samples. We, in collaboration with Anda Biologicals, have developed a new platform,
named as ‘‘Patho-tb”, for rapid detection of AFB with high sensitivity and with low dependence
on human skills. Evaluation of Patho-tb test performance was done in two settings: (1) primary field
study conducted using 38 sputa from high TB prevalence area of Iran (Zabol city near to the
Afghanistan border), and (2) main study conducted using 476 sputa from Tehran, capital of Iran.
Patho-tb was applied for processed sputum samples in parallel with routine diagnostic methods
(including AFB microscopy, culture and PCR). All test results were compared to final clinical
diagnostic state of an individual and diagnostic sensitivity (DSe), specificity, positive predictive
value, negative predictive value and accuracy of each test results were calculated using standard
formulations. Analytical sensitivity and specificity of the Patho-tb test were also determined.
Calculated values for five above mentioned parameters are as follows: for field study: AFB (DSe:
29.6, DSp: 81.8, PPV: 80, NPV: 23.1, AC: 44.7), Patho-tb (DSe: 63, DSp: 72.7, PPV: 85, NPV:
44.4, AC: 65.8), and for main study: AFB (DSe: 86.1, DSp: 99.4, PPV: 98.5, NPV: 93.9, AC:
95.2), Patho-tb (DSe: 97.4, DSp: 92.9, PPV: 86.5, NPV: 98.7, AC: 94.3). Reproducibility of
Patho-tb test results were near to 100% (Cohen’s kappa value between 0.85 and 1). The detection
limit of Patho-tb test with 100% positivity rate was 3  103 cells/ml of sputum. In the field study,Journal
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Please cite this article in press as: Nour-Neam
of Biological Sciences (2016), http://dx.doi.oPatho-tb test was 33.4% more sensitive than AFB microscopy, while the improvement was only
11.3% during the main study. Patho-tb results are easy to interpret and the test can be merged with
other screening tests, like AFB. Totally, Patho-tb test alone or in conjunction with AFB microscopy
is a useful screening tool for TB detection especially in poor geographical lab conditions.
 2016 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Traditionally, the detection of Mycobacterium tuberculosis
bacilli, MTB, in sputum establishes the diagnosis of TB. This
detection is made by the microscopic examination of sputa
and the visualization of acid fast bacilli (AFB) followed by cul-
ture to confirm the diagnosis (Schluger, 2008; WHO, 1998),
although it is now recognized that up to 22% of total TB cases
may be culture negative (CDC, 2006). Due to the cost and
difficulties of managing a reliable culture facility in many
TB-endemic countries and because of the length of time
required before obtaining results, all the prevailing institutions
agreed that diagnosis must be based on AFB microscopy in
rural areas (Odubanjo and Dada-Adegbola, 2011; Shea
et al., 2009). This method nevertheless is tedious, tiring, time
consuming and lacks sensitivity: globally only 45.6% of all
new and relapsed TB cases in 2004 were smear-positive
(WHO, 2006). Inexpensive rapid tests based on the detection
of anti-TB antibodies in the patients’ blood have been devel-
oped, but most performance studies reported much lower sen-
sitivity and specificity values than for AFB microscopy. Some
rapid tests seem to have good sensitivity but lack acceptable
specificity to be useful in most conditions (Adjei et al., 2003).
Other more sensitive and specific diagnostic tools, such as
direct PCR amplification tests (American, 1997), were devel-
oped with a sensitivity higher than 90% and a specificity close
to 100% in smear positive cases. These tests are ideal for
differentiating true TB infection from infections with non-
tuberculosis bacilli, NTB, but their overall sensitivity remains
too low. Lower sensitivity in smear negative cases, higher cost,
time required to perform and technical or material needs, in
collection, make them poor candidates for replacing micro-
scopy. We developed a test for the direct detection of bacilli
in sputum that is as sensitive as the Ziehl–Neelsen method,
but devoid of a strong dependence on technicians’ skills and
material. The new Patho-tb test was developed in collabora-
tion between our TB laboratory and Anda-Biologicals
(France). Our choice was a simple method based on filtration
of treated samples followed by visualization of the bacilli
trapped on the filter by an immuno-chromatographic method
using gold conjugate. In this paper, we report first some prac-
tical aspects of the Patho-tb test and then the results of a trial
made to compare culture, AFB microscopy and the new test
(see Fig. 1).
2. Materials and methods
2.1. Materials
‘‘Mycobacteria Patho-tb” rapid diagnostic kit, positive and neg-
ative controls (in freeze-dried format with sodium azide), solu-
tions for sample processing; neutralizing and dissolving, andatollahi, A. et al., A new diagnostic too
rg/10.1016/j.sjbs.2016.01.026other required reagents were provided by Pasteur Institute of
Iran (PII) and Anda Biologicals, (www.anda-biologicals.com),
as a compact ready to use kit. Purified rabbit anti-TB antibodies
were produced in PII and colloidal gold conjugated goat anti-
rabbit antibodies were purchased from sigma (G7277 SIGMA).
Ziehl Neelsen (ZN) acid-fast staining was performed according
to the CDCmanual (Kent and Kubica, 1985). AFBmicroscopy
results were categorized as negative, equivocal, 1+, 2+ and 3+.
For statistical comparisons the results were transformed into
binary format (negative or positive).
2.2. Culture conditions
Liquefied/decontaminated sputum samples were cultured on
Lowenstein-Jensen slant media for isolation and identification
of mycobacteria, according to the recommendations of both
CDC (Kent and Kubica, 1985) and IUATLD (Rieder et al.,
1998). The culture results were classified as negative when no
grown colonies were seen on the slant after 8 weeks of
incubation. Grown colonies were characterized and identified
to species by colony characteristics on culture slant media
and biochemical reactions. Contaminated culture results were
excluded from analysis.
2.3. PCR assay
Repetitive insertion sequence, IS6110-based PCR detection of
pathogenic TB was done (Abraham et al., 2012). DNA was
extracted using ‘‘High pure PCR template preparation kit”
(Roche; product No: 11796828001), and primer sets were
purchased from ‘‘DNA technology, Moscow, Russia”.
Oligonucleotide primers for PCR amplification of 123 bp tar-
get fragment were as follows: forward primer: 50-CCTGCGA
GCGTAGGCGTCGG-30 and reverse primer: 50-CTCGTCC
AGCGCCGCTTCGG-30. For further details see studies of
Bi et al. (1995) and Eisenach et al. (1990).
2.4. Patho-tb kit content
Patho-tb kit is made up of three main components: the filtra-
tion system, the decontamination system, and the rapid test
system. The filtration system, (the kit platform), consists of a
plastic cartridge; a funnel; and a glass fiber. The cartridge
has a cubic empty space usually fills with filtering and absorb-
ing layers and there is a circle opening located at the center
position. The cartridge fills in with one layer of thick porous
absorbing pad at the bottom and a layer of 0.45 micron pores
nitrocellulose membrane on the top. The funnel application
improves the sensitivity of the assay through focusing sample
and other test solutions in a small circle area (about 0.3 cm
in diameter). Enough glass fibers are also included in the kit










Figure 1 Patho-tb kit platform components. Vertical section from middle region of the platform is presented here. Body of the platform
is composed of the two main parts: a bottom part and a top part. The two parts will mount to each other using mounting site. One or
several absorbing pads are placed inside the platform and a nitrocellulose membrane filter exists that was located above the pads. In the
top-middle position of the platform is a hole that was allocated for transferring sample and other reagents on the membrane. Pre-filter,
made from glass fibers, was only devised for the first step of the assay, and its application is recommended for removing large particulate
materials that may be present in sputum samples and can clog up the main filter membrane. An elastic funnel is also designed to focus
sample and other reagents into a small circle area on the filter, and therefore amplify the observed color signal and also to economize in
materials and reagents.
Rapid and accurate detection of Mycobacterium tuberculosis 3as a pre-filter to remove large particulate matters from pro-
cessed sputum samples that may potentially clog the main
membrane (filter). The decontamination system, (the reagents
needed for sample preparation), includes the materials that
are needed to prepare kubica solution. The method is used
to digest and decontaminate viscose and highly contaminated
sputum samples (Morcillo et al., 2008). Clinical specimens
are usually associated with contaminating microorganisms
and organic debris. Kubica solution is used for killing any con-
taminating, fast growing microorganisms present in the sam-
ples, and for liquefying organic debris that may surround the
mycobacteria. Centrifugation of liquefied sample further con-
centrates the bacilli in the pellet and improves the possibility
of obtaining positive results through the later recognition/
detection steps. The rapid test system, (the main reagents to
carry out the Patho-tb assay), consists of dissolving and wash-
ing solutions; negative and positive controls; colloidal gold
conjugated goat anti-rabbit antibodies; and a purified anti-
body against MTB proteins (antigens) obtained via affinity
chromatography.
2.5. Antigen preparation
Mycobacterial cells, grown in 7H9 broth culture (after four
weeks of incubation at 37 C), were harvested and washed 3
times using phosphate buffered saline (PBS), (pH: 7.3), cen-
trifuged (3000 rpm, 15 min), and the pellet was mixed with
purification buffer (NaN3: 0.002 g/dl, Triton X100: 1%,
Glycerol: 10%, DTT: 10 mM, PMSF: 1 mM and EDTA:
20 mM, pH: 7.4), freezed (5 min, liquid nitrogen) and thawed
(5 min, boiling water) 30 cycles. The suspension was then
sonicated using a probe sonicator (50 Hz for one hour, under
safety cabinet), and centrifuged (4000 rpm, 15 min). The pellet
was discarded and the supernatant was mixed with absolute
ethanol, ETOH, (volumes of ETOH [99%, 20 C] were
added to the supernatant until the final concentration of
60% ETOH was achieved), and centrifuged (15000 rpm,Please cite this article in press as: Nour-Neamatollahi, A. et al., A new diagnostic too
of Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.01.02630 min). The protein rich pellet was resuspended in PBS buffer
(pH: 7.3), and dialyzed in three steps against the buffer. Pro-
tein concentration of the final solution was determined using
Bradford assay.
2.6. Preparation of TB-specific antibodies
Antibodies were used for recognizing and binding to the
mycobacteria cells retained on nitrocellulose membrane pores.
Anti-TB antibodies were produced in PII TB reference labora-
tory. Polyclonal TB-specific antibodies were raised in rabbits
using a well-established immunization protocol. Briefly,
250 ll from the working solution of purified mycobacterial
proteins (1 mg/1 ml) was emulsified in 250 ll of incomplete fre-
und’s adjuvant and subcutaneously injected to each rabbit four
times with three week intervals (at 0, 21, 42 and 63 days). TB-
specific antibody levels in immunized rabbit serums were con-
tinuously monitored using ELISA system. Finally, blood from
rabbits was obtained at 66 days, and the serum fractions were
separated using centrifugal force (2500 rpm, 20 min).
2.7. Purification of the antibodies
Rabbit sera were subjected to further purification using
CNBr-activated TB-antigens coupled Sepharose 4B column
chromatography. The precipitated dialyzed protein solution
(TB-antigens) was coupled to CNBr-activated Sepharose 4B
beads (2.4 mg protein per 1 g beads) and the remaining free
sites were blocked using ethanolamine (3.4 ml ethanolamine
added to 996.6 ml carbonate–bicarbonate buffer, 0.05 M).
The column was washed with glycine buffer (0.2 M, pH: 2.8)
until the optical density (OD) of eluted solution read 0 value
at 280 nm indicating complete removal of loose bound pro-
teins from the column. The column was washed with tris buffer
(0.1 M, pH: 7.3) and filled with 500 ll of rabbit immune sera,
incubated at RT for 1 h. The column washed with tris buffer to
remove unbound proteins. To elute bound Ab(s) glycine bufferl for rapid and accurate detection of Mycobacterium tuberculosis. Saudi Journal
4 A. Nour-Neamatollahi et al.(0.1 M, pH: 2.8) was added and eluted solution was monitored
using spectrophotometer until the OD reached to zero value.
Tubes containing TB-specific polyclonal antibodies were col-
lected and dialyzed against PBS (membrane pore size 10,000,
overnight incubation, repeated three steps). ELISA assay was
used for Ab titration and the Abs were absorbed for removing
non-specific Abs.
2.8. Absorption process
For achieving the highest specificity of theTB recognition and to
eliminate the non-specific reactions, the purified polyclonal anti-
bodies were absorbed against TB-negative (smear-, culture-,
PCR-), diluted, and pH adjusted (pH: 9.6), sputum samples
(300 sputa from our sample bank that had been double-
checked and confirmed as smear, PCRand culture negative sam-
ples). In other words, a TB-negative sputum refers to a sputum
sample collected from a TB-negative individual, processed
through a standard procedure and evaluated using three tests
and retained negative results by all three methods, AFB, culture
and PCR analysis. Several ELISA plates coated with the sputa
were used for absorption process. Briefly, initially processed,
then pooled, TB-negative sputa were diluted using carbonate/
bicarbonate coating buffer (Na2CO3: 3.03 g; NaHCO3: 6.0 g;
pH: 9.6; final volume 1000 ml), transferred to the wells of micro-
titer plate (120 ll/well) and incubated for 24 h at 4 C.Unbound
sites were blocked using bovine serum albumin (Bovine serum
albumin fraction V: 1% and 200 ll/well; o/n; at 4 C). Excess
liquid discarded from the wells (under safety cabinet), Ab solu-
tion was added and incubated (100 ll/well; 2 h; at RT, with gen-
tle agitation). The absorption process was repeated two times in
another set of coated plates to remove existing non-specific Ab
(s). Finally, the absorbed Ab was collected and aliquoted in
1 ml cryotubes and kept at 20 C.
2.9. Population and samples
Evaluation of Patho-tb kit performance was carried out in two
separate times and settings. Primary study for evaluation of
Patho-tb diagnostic performance was conducted on April
2011 using sputum samples collected from 38 TB-suspected
individuals from Zabol city (located near to the Afghanistan
border of Iran), with high TB prevalence (109.7 per 100,000
population) (Iran’s Ministry of Health Report, 2011;
Metanat et al., 2012). Three consecutive samples were collected
on three separate days. Under the geographical conditions the
only diagnostic measure could be acid fast staining applied to
the partially processed sputum samples and usually observed
by inexperienced staffs (compared to reference laboratories).
Patho-tb test was applied in parallel with routine acid fast
bacilli detection task. However, PCR-based detection of TB
bacilli for each sputum sample was done in reference labora-
tory in Pasteur Institute of Iran (in Tehran capital of Iran).
Main study was started from Jan 2011 and lasted up to the
end of 2014. Totally 476 fresh sputa samples were collected
from active pulmonary tuberculosis (PTB) suspected patients,
from Tehran province, referred to TB reference laboratory by
referring laboratories or clinicians, examined for AFM, TB-
specific culture, PCR amplification and also by Patho-tb
assays. Repeated sample collection was only done if the pri-
mary sample results were negative or unreliable. The definitivePlease cite this article in press as: Nour-Neamatollahi, A. et al., A new diagnostic too
of Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.01.026diagnosis of active TB-infection, is based on the collective
results of the laboratory tests, CXR, and patient’s clinical
manifestation.
2.10. Sample processing
Sample collection and processing were done according to
WHO, CDC recommendations. A code number was assigned
to each sputum sample and assayed in a blinded manner by
operators and the results were decoded during final analysis.
Kubica solution was used for sample digestion and decontam-
ination according to the kit manual. Briefly, equal volumes
(2 ml) of sputum and freshly prepared kubica solution were
mixed in a 50 ml conical centrifuge tube and incubated at room
temperature for 20 min. The mixture was neutralized with
18 ml of neutralizing buffer and centrifuged for 20 min at
4000 rpm. The supernatant discarded and the resulting pellet
was resuspended in 1–5 ml of neutralizing buffer (depending
on the pellet viscosity). Equal volumes (0.1 ml) of the resus-
pended pellet and dissolving solution were mixed in a boiling-
resistant microtube and floated in boiling water bath for
20 min using a floating support. The remaining pellet was used
for microbiological examination and acid-fast microscopy.
2.11. Patho-tb assay procedure
The cartridge was mounted using one piece of pre-filter and a
funnel. Processed and boiled sample (100 ll) was immediately
loaded on the pre-filter surface and allowed to be absorbed.
After washing (3 times using 50 ll wash buffer), pre-filter
was removed and the funnel was mounted again. Anti-TB anti-
bodies (50 ll) were then added and allowed to drain. Two
drops of anti-rabbit Ab-gold conjugates were added followed
by a washing step. The funnel was removed and washed again.
Development of a red-pink color on the center of membrane
indicates the presence of tuberculosis bacilli in the sample.
Wash buffer is composed of PBS supplemented with 0.1%
Tween 20 and sodium mercurothiolate as preservative. Both,
positive control (killed M. tuberculosis 1137 Ra) and negative
control were included in the kit and processed according to
the kit manual. Briefly, digestion/decontamination step was
omitted and equal volumes (100 ll) of the two controls and
dissolving solution were mixed, boiled and assayed in parallel
with test samples.
2.12. Interpretation of the results
Developed central red-pink color was observed and judged in
comparison with negative control result(s). Any red-pink ring
around the test area was considered as an artifact. Doubtful
results (weak red-pink signal) were re-assayed using new sam-
ples. The color intensity is proportional to the density of
mycobacteria trapped in the filter. The results were expressed
as negative or positive.
2.13. Repeatability of the assay
Repeatability defines as intra-laboratory variability of the
results. Result variability may be divided into run-to-run
variability with the same operator, inter-operator variability,l for rapid and accurate detection of Mycobacterium tuberculosis. Saudi Journal
Table 1 Classification of cases using combination of test
results (primary study).
Total cases Diagnosis PCR AFB Patho-tb No. of cases
38 27+ + + + 8
+ FN + 9
+ FN FN 10
11 FP FP FP 2
FP  FP 1
FP   1
   7
FN: false negative; FP: false positive; +: true positive; : true
negative.
Rapid and accurate detection of Mycobacterium tuberculosis 5inter-equipments or inter-batch variability. Reference samples
with long term stability under preservation conditions for
measuring repeatability did not exist. Home-made reference
samples using cultured mycobacteria diluted in confirmed
TB-negative sputa showed low stability under preservation
conditions. Notable signal reduction of the prepared reference
samples was observed after three days of preservation at 4 C
or after 10 days preservation at 20 C. Despite the difficul-
ties, positive reference samples were prepared and aliquoted,
using cultured M. tuberculosis, at final concentrations of
3  108, 1  107 and 1  105 cells/ml, diluted in TB-negative
pooled sputa, preserved in 20 C, and assayed utmost
10 days by different operators. Aliquots from the pooled sputa
lacking MTB were used as negative control. The reference
samples were assayed in parallel with the tests. Intra-assay or
inter-assay agreement of the results from repeated measures
was calculated using Cohen’s kappa statistical test.
2.14. Analytical sensitivity and specificity
A homogenous suspension of M. tuberculosis, equal to one
McFarland standard turbidity (3  108 cells/ml, in PBS), was
prepared, from which, 10-fold serial dilutions were made and
100 ll from each dilution was mixed with 900 ll pooled,
homogenized, TB-negative sputa, and assayed as field samples,
in a blind manner, by different operators. Dilution factors
were considered in the calculations of MTB density in refer-
ence sputum samples.
Cross reactivity of the test: In a comparative study, suspen-
sions equal to one McFarland standard turbidity from the fol-
lowing species were prepared: M. tuberculosis, Mycobacterium
avium, Mycobacterium bovis, Mycobacterium bovis BCG,
Mycobacterium fortuitum, Mycobacterium intracellulare,
Mycobacterium kansasii, Mycobacterium scrofulaceum and
Mycobacterium smegmatis. Three dilutions (3  107, 3  105
and 3  103 cells/ml in PBS) from each species were prepared
and assayed with Patho-tb and compared.
2.15. Diagnostic sensitivity and specificity
Culture is considered as a gold standard among laboratory
tests for MTB, however, determination of condition index
(presented as ‘‘diagnosis” in tables), for an individual relies
on the collection of clinical manifestation and paraclinical test
results, including AFM, culture, PCR, CXR, TST. Therefore,Please cite this article in press as: Nour-Neamatollahi, A. et al., A new diagnostic too
of Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.01.026true positive (TP), true negative (TN), false positive (FP) and
false negative (FN) nature of the test results were determined
through comparing each result with collectively determined
infectious index of the patient.
3. Results
3.1. Primary study results
Result distribution of three MTB diagnostic tests, AFB; PCR;
and Patho-tb, for 38 PTB suspected patients from Zabol is pre-
sented in Table 1. Performance characteristics of the tests are
provided in Table 3.
3.2. Main study results
The main study was conducted in reference laboratory using
fresh sputum samples from 476 PTB suspected patients. Result
distribution of culture; AFM; PCR; Patho-tb tests for the
patients is presented in Table 2. The data can be used for
regeneration of full lists of results as a worksheet. Performance
characteristic of the test is provided in Table 3.
3.3. Comparison of assay performances
Performance characteristics of the 4 tests in both primary and
main studies are presented in Table 3.
3.4. Repeatability
TB-negative sputa were spiked and used as positive reference
samples. Final concentrations of 1  108, 1.5  106 and
1  105 bacterial cells/ml were used to define intra-laboratory
reproducibility of the Patho-tb assay. TB-negative sputa
(smear-, culture-, PCR-), were also used as a negative reference
sample. Results of positive and negative reference samples
were used for calculation of agreement coefficient by Cohen’s
kappa statistical test. The calculated Kappa values for refer-
ence samples containing 1  108, 1.5  106 cells/ml were
always equal to one, but for lower concentration, 1  105
cells/ml, the calculated Kappa value ranged from 0.85 to 1.
Cohen’s kappa usually ranges from zero to one. Zero shows
overall disagreement, while one means full agreement between
repeated measurements.
3.5. Analytical sensitivity
Pooled TB-negative sputa were spiked with serial dilutions of
MTB. The reference samples treated the same way as worked
with field samples. The detection limit of Patho-tb assay with
100% positivity rate was 3  103 cells/ml of sputum. Mean
positivity rate obtained from concentrations of 3  102 cells/
ml (equal to 300 mycobacteria on filter paper) was 32%. Please
note that, the final density of MTB in 1 ml processed sputum
(not in PBS) was considered in final report.
3.6. Analytical specificity
Cross-reactivity of recognizing rabbit polyclonal TB-specific
antibody to non-pathogenic mycobacteria was assessed. Finall for rapid and accurate detection of Mycobacterium tuberculosis. Saudi Journal








476 151+ + + + + 111
+ + + FN 1
+ + FN + 18
+ + FN FN 3
+ FN + + 18
325 FP   + 13
FP    15
  FP FP 1
  FP  1
   FP 9
    286
Diagnosis, in fact, represents the final infectious state of the indi-
viduals (used as gold standard to calculate PPV, NPV, DSe, DSp
and AC). 151 out of 476 patients were diagnosed as active PTB
(Prevalence: 31.7%). FN: false negative; FP: false positive; +: true
positive; : true negative.
6 A. Nour-Neamatollahi et al.signal strength was 10 to 100 fold lower in non-pathogenic
mycobacteria compared to pathogenic species. That means
very high density of non-pathogenic mycobacteria is required
to possess interfering effects on pathogenic TB recognition.
Descending order of final signal strength caused by
non-pathogenic species is as follows: M. avium>
M. bovis>M. bovis BCG>M. fortuitum>M. intracellulare>
M. kansasii>M. scrofulaceum>M. smegmatis.
4. Discussion
The best diagnostic tool for TB detection is generally accepted
to be culture (Schluger, 2008; WHO, 1998). Indeed, most
authors have reported a good sensitivity (90–100%) for this
method in pulmonary cases (Lu et al., 1996) and it is generally
accepted that it is almost 100% specific. Nevertheless, the total
number of positive TB cases that are culture negative in the
USA reached 22% in 2005 (CDC, 2006) and certain studiesTable 3 Performance characteristics of culture; PCR; AFB and Pa
Method Final interpretation (No. of specimen)
TP FP TN FN
Primary study AFB 8 2 9 19
PCR 27 4 7 0
Patho-tb 17 3 8 10
Main study Culture 133 0 325 18
PCR 151 28 297 0
AFB 130 2 323 21
Patho-tb 147 23 302 4
DSe: diagnostic sensitivity; DSp: diagnostic specificity; PPV: positive pre
123 bp IS6110 fragment; AFB: acid fast bacilli microscopy; Patho-tb: A
was not possible during the primary study because of poor resource. PC
reference laboratory, in Tehran. Primary study: 27 out of the 38 suspecte
cases were classified as negative. Main study prevalence of PTB was 31.7
Please cite this article in press as: Nour-Neamatollahi, A. et al., A new diagnostic too
of Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.01.026report sensitivities of 50% or lower in special patient groups
(Delacourt et al., 1993; Burman et al., 1997; Chiang et al.,
1997; Swanimathan and Umadevi, 1999). While it remains
the gold standard for TB detection, more than 8 weeks length
of time is required to yield results, and poor financial or staff
resources in TB-endemic area does not usually support imple-
menting the technique in the location. Therefore, AFB detec-
tion by microscopy is advocated in its place.
AFB microscopy is cheap, except for the microscope,
requires little material and gives results in a day. On the other
hand, it is a tiring and cumbersome technique that relies heav-
ily on technician’s skill, quality of chemicals and human inter-
pretation. Since 1975 individual studies (Boyd and Marr, 1975;
Lipsky et al., 1984; Levy et al., 1989; Karstaedt et al., 1998)
reported a great disparity in the sensitivity values, from 33%
to 80%, depending on the group studied, incidence of TB in
the area, sputum dissolving techniques, staining techniques
and the number of samples tested per patient. The most recent
global report (WHO, 2006) indicates that even among PTB
cases the sensitivity of this method is only 40–58%. Although
AFB microscopy is believed to be very specific, however, the
differential identification of mycobacterium species by mor-
phological parameters is almost impossible.
In our study, DSe and DSp of AFB microscopy in poor
area lab and in reference lab were 29.6%, 81.8% and 86.1%,
99.4%, respectively. The low DSe value (29.6%) of the method
in poor area lab, compared to reference lab (86.1%), is indica-
tive of determinant influence of technician’s skill and working
conditions on accuracy of the test results. Simultaneously, the
DSe value for Patho-tb test results under the poor area lab
conditions was 63%, that means Patho-tb test is twofold more
sensitive than AFB microscopy. The DSe of Patho-tb test was
also higher in reference lab conditions compared to AFB
(97.4% against 86.1%). Negative predictive value of Patho-
tb test is also higher in poor lab conditions compared to
AFB microscopy (44.4% against 32.1%), and even in reference
lab conditions (98.7% against 93.9%). Eighteen out of 21
AFB-negative samples (from reference lab) and nine out of
19 AFB-negative samples (from poor conditions) were accu-
rately diagnosed as positive by Patho-tb test. In collection,
Patho-tb test results are more sensitive and more accurate than
AFB microscopy, but the intervals were obviously higher intho-tb tests in diagnosis of active PTB.
DSe (%) DSp (%) PPV (%) NPV (%) AC (%)
29.6 81.8 80.0 32.1 44.7
100.0 63.7 87.1 100.0 89.5
63.0 72.7 85.0 44.4 65.8
88.1 100.0 100.0 94.8 96.2
100.0 91.3 84.3 100.0 94.1
86.1 99.4 98.5 93.9 95.2
97.4 92.9 86.5 98.7 94.3
dictive value; NPV: negative predictive value; PCR: routine PCR for
new kit from Anda Biologicals. Culture for M. tuberculosis isolation
R test for primary study was done on preserved samples, later in my
d cases (prevalence: 71%), were indexed as having active PTB and 11
% (151+/476).
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against 44.7%). The higher sensitivity and the higher negative
predictive value of the Patho-tb test make it the best screening
test among the three, especially in the poor conditions.
Contrary to the AFB microscopy, the Patho-tb test is a
straightforward and easy to perform method, allowing an
average of 30 samples to be treated simultaneously. Twenty
minute heating of processed samples on boiling water makes
the sample non-infectious, and therefore, protects technicians
from acquiring the disease. The results of the tests are easy
to interpret and rely far less on individual interpretation.
The agreement of Patho-tb results (kappa coefficient) between
different operators and between separate days was about 0.85
to 1 that indicates technician’s skill independency of the test
results. Inclusion of the Kubica solutions in the kit has the
advantage of increasing the robustness of the kit by limiting
lab-to-lab variations in decontamination procedures. The test
results are also highly reproducible. All five technicians
involved with the test in our lab indicated a preference for a
less cumbersome technique. Treating 30 samples or more at
the same time in about 2 h was greatly appreciated. The needed
centrifuge and water bath are standard equipments in most
field laboratories in our country. When all financial parameters
are taken into account, the test is inexpensive and its selling
price should be close to that of microscopy.
The preliminary field trial in Zabol (Table 1) was made
under more difficult conditions. The equipments had lesser
quality and the technicians were less experienced. The reported
accuracy of the Patho-tb test (65.8%) is thus far higher than
that of microscopy (44.7%). Although the Zabol trial was lim-
ited in scope, it shows that the Patho-tb test, as a screening
assay, is more suitable for use in field labs than microscopy.
The higher sensitivity of Patho-tb test partly depends on the
quality of recognizing antibodies included in the kit, which
have been produced and purified in our lab. High quality
TB-specific polyclonal antibodies were raised in rabbits, a
good antibody producer. Several absorption steps were imple-
mented to remove cross-reactive antibodies and minimizing
background signals. However, cross-reactivity of the antibody
to other mycobacteria is inevitable. Indeed, in a try in our lab-
oratory, absorption of the rabbit antisera using non-
pathogenic mycobacteria resulted in significant reduction in
the test signal, and therefore, leads to reduction in the test sen-
sitivity, thus, absorption with non-pathogenic mycobacteria
was omitted. Presence of non-pathogenic mycobacteria in pul-
monary samples is a rare event, but during examination of
extra-pulmonary samples positive results should be related to
the observed clinical signs and to the nature of the specimen.
PCR-based detection of MTB in sputum samples from the
two study settings was done in the reference lab. The DSe and
DSp values for PCR-based detection of MTB in samples from
preliminary and secondary studies were 100%, 63.7% and
100%, 91.3%, respectively. The calculated accuracy of PCR
assay in the field lab setting was 89.5%, that is significantly
higher than the accuracies of AFB (44.7%) and Patho-tb
(65.8%) tests, however, facilities for implementing the test
were not available in the endemic area. In contrast to some
reports from India about absence of even a single copy of
IS6110 in 1% of MTB isolates, all of 514 MTB isolates in
the current study were positive for the presence of the gene
sequence (Balamurugan et al., 2006). In one study by analysis
of 49 sputum samples, the rate of smear and culture negativityPlease cite this article in press as: Nour-Neamatollahi, A. et al., A new diagnostic too
of Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.01.026was 75%, of which, 85% yielded positive results using IS6110
based PCR (Abraham et al., 2012). The other survey by
Farzam et al. (2015), has reported 95.1% and 42.9% sensitivity
values of the IS6110 PCR assay for culture isolates and direct
specimens, respectively. Indeed, IS6110 PCR based assay was
able to detect 10 copies of MTB in the specimens (Nghiem
et al., 2015).5. Conclusion
In terms of ease of use, duration, ease of interpretation,
robustness, reproducibility and record-keeping the Patho-tb
test we developed meets or even exceeds AFB microscopy
and culture. It was demonstrated that the Patho-tb test was
33.9% more sensitive and 21.1% more accurate than AFB
microscopy. The test was technician’s skill independent and
can easily be incorporated in the general processing of sputa
samples for TB diagnosis and is especially useful as a screening
test for TB detection, especially in poor facility and poor
human resource conditions.References
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